Register entry

BridgeBio Pharma, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
13
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

13
PatentProductCoversExpiry
10398681ATTRUBYacoramidis hydrochlorideproductMay 2031
10842777ATTRUBYacoramidis hydrochlorideuseMay 2031
8877795ATTRUBYacoramidis hydrochlorideproductMay 2031
9169214ATTRUBYacoramidis hydrochlorideproductMay 2031
9642838ATTRUBYacoramidis hydrochloridesubstance, productMay 2031
9913826ATTRUBYacoramidis hydrochlorideuseMay 2031
10513497ATTRUBYacoramidis hydrochloridesubstanceFeb 2038
11919865ATTRUBYacoramidis hydrochlorideuseFeb 2038
11058668ATTRUBYacoramidis hydrochlorideuseMar 2039
12070449ATTRUBYacoramidis hydrochlorideuseMar 2039
11260047ATTRUBYacoramidis hydrochlorideproductAug 2039
12005043ATTRUBYacoramidis hydrochlorideproductAug 2039
12539290ATTRUBYacoramidis hydrochlorideproductAug 2039
ProductExclusivityUntil
ATTRUBYACORAMIDIS HYDROCHLORIDEODE-506 Orphan drugNov 2031
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
Attrubyacoramidis hydrochloridetablet, film coated, oral82228-712NDA
Compare

Other companies listing acoramidis hydrochloride

Enquiry

Common questions

Is BridgeBio Pharma, Inc. FDA approved?
BridgeBio Pharma, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does BridgeBio Pharma, Inc. make?
1 product is listed under BridgeBio Pharma, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.